Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples
- 14 March 2006
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 25 (3) , 167-174
- https://doi.org/10.1007/s10096-006-0112-4
Abstract
The aim of the present study was to compare traditional methods for the detection of respiratory syncytial virus with a newly developed commercial assay based on real-time nucleic acid sequence based amplification. Respiratory syncytial virus is a major cause of severe respiratory infection in infants and in certain groups of older children and adults. Treatment options are limited, but a rapid diagnosis improves patient management and infection control. The rapid diagnosis of respiratory syncytial virus currently relies on antigen detection assays. These tests are limited to use in certain good-quality types of samples, which are rarely obtained from adult patients. Molecular-based assays for the detection of respiratory syncytial virus are shown to be highly sensitive, specific, and more rapid than cell culture techniques. This retrospective study compared traditional laboratory techniques for the detection of respiratory syncytial virus in 508 respiratory samples collected during the winter months of 2003–2004 against the recently developed, commercially available NucliSens EasyQ Respiratory Syncytial Virus A+B assay (bioMérieux, Marcy l’Etoile, France), which is based on real-time nucleic acid sequence based amplification using molecular beacons and an internal control. Using traditional techniques, the prevalence of respiratory syncytial virus in the samples tested was found to be 21%. Using the real-time nucleic acid sequence-based amplification assay, an additional 41 samples from patients with a clinically diagnosed respiratory illness were found to be positive for respiratory syncytial virus. The NucliSens EasyQ assay was shown to be sensitive and specific for the detection of respiratory syncytial virus A+B in different types of respiratory samples. Moreover, the time required to complete the assay was <4 h, so results could be obtained on the same day as sample receipt in the laboratory.Keywords
This publication has 37 references indexed in Scilit:
- Development and evaluation of a real‐time nucleic acid sequence based amplification assay for rapid detection of influenza AJournal of Medical Virology, 2004
- Rapid and Sensitive Method Using Multiplex Real-Time PCR for Diagnosis of Infections by Influenza A and Influenza B Viruses, Respiratory Syncytial Virus, and Parainfluenza Viruses 1, 2, 3, and 4Journal of Clinical Microbiology, 2004
- Stable and Noncompetitive RNA Internal Control for Routine Clinical Diagnostic Reverse Transcription-PCRJournal of Clinical Microbiology, 2004
- Multiplex Real-Time PCR Assay for Detection of Influenza and Human Respiratory Syncytial VirusesJournal of Clinical Microbiology, 2004
- Advances in the laboratory diagnosis of viral respiratory diseaseThe Pediatric Infectious Disease Journal, 2004
- Simultaneous Detection, Subgrouping, and Quantitation of Respiratory Syncytial Virus A and B by Real-Time PCRJournal of Clinical Microbiology, 2003
- Diagnosis of Respiratory Syncytial Virus Infection: Comparison of Reverse Transcription-PCR to Viral Culture and Serology in Adults with Respiratory IllnessJournal of Clinical Microbiology, 2002
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000
- Respiratory Syncytial Virus Genetic and Antigenic DiversityClinical Microbiology Reviews, 2000
- Respiratory syncytial virus infections in infants: Quantitation and duration of sheddingThe Journal of Pediatrics, 1976